4.7 Article

Targeting NPM1 in irradiated cells inhibits NPM1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLC

期刊

CANCER LETTERS
卷 500, 期 -, 页码 220-227

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2020.12.023

关键词

Nucleophosmin1; YTR107; Radiation sensitization; RAD51; NSCLC

类别

资金

  1. NIH/NCI [R44CA228756]
  2. Vanderbilt-Ingram Cancer CTR Grant [P30 CA68485]

向作者/读者索取更多资源

Nucleophosmin1 (NPM1) is over-expressed in NSCLC, promoting tumor growth and correlating with lower survival probability. YTR107, a small molecule radiation sensitizer, inhibits SUMOylated NPM1 from associating with RAD51, enhancing radiation-induced cell lethality. The data suggest that YTR107 represents a potential therapeutic target for NSCLC control.
The ability of chemo-radiation therapy to control locally advanced stage III non-small cell lung cancer (NSCLC) is poor. While addition of consolidation immunotherapy has improved outcomes in subsets of patients there is still an urgent need for new therapeutic targets. Emerging research indicates that nucleophosmin1 (NPM1) is over-expressed in NSCLC, promotes tumor growth and that over-expression correlates with a lower survival probability. NPM1 is critical for APE1 base excision activity and for RAD51-mediated repair of DNA double strand breaks (DSBs). YTR107 is a small molecule radiation sensitizer that has been shown to bind to NPM1, suppressing pentamer formation. Here we show that in irradiated cells YTR107 inhibits SUMOylated NPM1 from associating with RAD51, RAD51 foci formation and repair of DSBs. YTR107 acts synergistically with the PARP1/2 inhibitor ABT 888 to increase replication stress and radiation-induced cell lethality. YTR107 was found to radiosensitize tumor initiating cells. Congruent with this knowledge, adding YTR107 to a fractionated irradiation regimen diminished NSCLC xenograft growth and increased overall survival. These data support the hypothesis that YTR107 represents a therapeutic target for control of NSCLC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据